Reach Separations Marks 10th Birthday Milestone With Further Expansion Into EuropeGemma Cann2024-11-28T14:54:18+00:00May 17th, 2022|BioCity Nottingham, News|
Sygnature Discovery Acquires Peak ProteinsGemma Cann2022-06-30T11:28:07+01:00April 28th, 2022|BioCity Nottingham, News|
OMass Therapeutics Raises $100 million To Progress Drug Pipeline In Immunology And Rare DiseasesGemma Cann2024-11-28T14:55:20+00:00April 28th, 2022|BioCity Nottingham, News|
Milestone Anniversary ‘A Proud Landmark’ For V Formation’s DirectorsGemma Cann2025-08-11T11:52:26+01:00April 26th, 2022|BioCity Nottingham, News|
Cellomatics Biosciences Wins Queen’s Award For EnterpriseGemma Cann2024-11-28T14:56:21+00:00April 21st, 2022|BioCity Nottingham, News|
Platelet Services Appoints Senior Research Scientist To Support GrowthGemma Cann2024-11-28T14:56:55+00:00March 30th, 2022|BioCity Nottingham, News|
From Kitchen Ingredient To Saving Lives – Phenotypeca Pioneers Improved Use Of Baker’s YeastGemma Cann2024-11-28T15:13:44+00:00March 10th, 2022|BioCity Nottingham, News|
Winners Announced For Medilink Midlands Business Awards 2022Gemma Cann2024-11-28T15:16:09+00:00February 15th, 2022|BioCity Nottingham, MediCity Nottingham, News|
Nottingham CRO Bolsters Team With Appointment Of Senior Molecular BiologistGemma Cann2024-11-28T15:29:53+00:00February 14th, 2022|BioCity Nottingham, MediCity Nottingham, News|
Phenotypeca Announces Commencement Of Lab 4.0 ProjectGemma Cann2024-11-28T15:16:33+00:00February 4th, 2022|BioCity Nottingham, News|
